Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Warfarine")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 4129

  • Page / 166
Export

Selection :

  • and

Warfarin embryopathy: fetal manifestationsWAINWRIGHT, Helen; BEIGHTON, Peter.Virchows Archiv. 2010, Vol 457, Num 6, pp 735-739, issn 0945-6317, 5 p.Article

Warfarin reversalHANLEY, J. P.Journal of clinical pathology. 2004, Vol 57, Num 11, pp 1132-1139, issn 0021-9746, 8 p.Article

The interaction between fluvastatin and warfarinWANG, Hui-Ting; CHEN, Yung-Lung.International journal of cardiology. 2012, Vol 155, Num 1, pp 167-168, issn 0167-5273, 2 p.Article

Optimal initial dose adjustment of warfarin in orthopedic patientsLENZINI, Petra A; GRICE, Gloria R; GAGE, Brian F et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 11, pp 1798-1804, issn 1060-0280, 7 p.Article

Warfarin-induced tracheobronchial calcificationTHOONGSUWAN, Nisa; STERN, Eric J.Journal of thoracic imaging. 2003, Vol 18, Num 2, pp 110-112, issn 0883-5993, 3 p.Article

The development and application of a surface plasmon resonance-based inhibition immunoassay for the determination of warfarin in plasma ultrafiltrateFITZPATRICK, Brian; O'KENNEDY, Richard.Journal of immunological methods. 2004, Vol 291, Num 1-2, pp 11-25, issn 0022-1759, 15 p.Article

The story of the discovery of heparin and warfarinWARDROP, Douglas; KEELING, David.British journal of haematology. 2008, Vol 141, Num 6, pp 757-763, issn 0007-1048, 7 p.Article

Probable Interaction Between Warfarin and TorsemideBIRD, Jennifer; CARMONA, Carlos.The Annals of pharmacotherapy. 2008, Vol 42, Num 12, pp 1893-1898, issn 1060-0280, 6 p.Article

Warfarin: from bedside to BenchWESSLER, S; GITEL, S.The New England journal of medicine. 1984, Vol 311, Num 10, pp 645-652, issn 0028-4793Article

A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistanceLOEBSTEIN, Ronen; DVOSKIN, Iiana; GAK, Eva et al.Blood. 2007, Vol 109, Num 6, pp 2477-2480, issn 0006-4971, 4 p.Article

Influence of the VKORC1 3730 G > A polymorphism on warfarin doseSKOV, Jane; BLADBJERG, Else-Marie; JESPERSEN, Jørgen et al.European journal of clinical pharmacology. 2013, Vol 69, Num 4, pp 1043-1044, issn 0031-6970, 2 p.Article

Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian populationLEE, Soo-Chin; NG, Swee-Siang; NG, Kheng-Siang et al.Clinical pharmacology and therapeutics. 2006, Vol 79, Num 3, pp 197-205, issn 0009-9236, 9 p.Article

Warfarin-induced skin necrosisNAZARIAN, Rosalynn M; VAN COTT, Elizabeth M; ZEMBOWICZ, Artur et al.Journal of the American Academy of Dermatology. 2009, Vol 61, Num 2, pp 325-332, issn 0190-9622, 8 p.Article

Identification of the gene for vitamin K epoxide reductaseTAO U; CHANG, Chun-Yun; JIN, Da-Yun et al.Nature (London). 2004, Vol 427, Num 6974, pp 541-544, issn 0028-0836, 4 p.Article

WARFARIN THERAPY : INFLUENCE OF PHARMACOGENETIC AND ENVIRONMENTAL FACTORS ON THE ANTICOAGULANT RESPONSE TO WARFARINSIGURET, Virginie; PAUTAS, Eric; GOUIN-THIBAULT, Isabelle et al.Vitamins and hormones. 2008, Vol 78, pp 247-264, issn 0083-6729, 18 p.Article

Fluorescence Enhancement of Warfarin Induced by Interaction with β-CyclodextrinVASQUEZ, Jacob M; VU, Andrew; SCHULTZ, Jerome S et al.Biotechnology progress. 2009, Vol 25, Num 4, pp 906-914, issn 8756-7938, 9 p.Conference Paper

Reversible endotension associated with excessive warfarin anticoagulationIYER, Vikram S; MACKENZIE, Kent S; CORRIVEAU, Marc-Michel et al.Journal of vascular surgery. 2007, Vol 45, Num 3, pp 600-602, issn 0741-5214, 3 p.Article

The influence of VKORC1 3730 G > A polymorphism on warfarin dose: replyCINI, Michela; LEGNANI, Cristina; COSMI, Benilde et al.European journal of clinical pharmacology. 2013, Vol 69, Num 4, issn 0031-6970, p. 1045Article

Solving the mystery of excessive warfarin-induced bleeding: A personal historical perspectiveHIRSH, Jack.Thrombosis and haemostasis. 2014, Vol 112, Num 5, pp 853-856, issn 0340-6245, 4 p.Article

The impact of VKORC1-1639G > A genetic polymorphism upon warfarin dose requirement in different ethnic populationsBO JIN; YONG HONG; JUN ZHU et al.Current medical research and opinion. 2014, Vol 30, Num 8, pp 1505-1511, issn 0300-7995, 7 p.Article

Influence of ORM1 polymorphisms on the maintenance stable warfarin dosageLIAN SHENG WANG; JING JING SHANG; ZHI LI et al.European journal of clinical pharmacology. 2013, Vol 69, Num 5, pp 1113-1120, issn 0031-6970, 8 p.Article

Influence of APOE genotypes and VKORC1 haplotypes on warfarin dose requirements in Asian patientsLAL, Suman; SANDANARAJ, Edwin; SRINIVASA RAO JADA et al.British journal of clinical pharmacology. 2008, Vol 65, Num 2, pp 260-264, issn 0306-5251, 5 p.Article

VKORC1 Asp36Tyr geographic distribution and its impact on warfarin dose requirements in EgyptiansSHAHIN, Mohamed Hossam A; CAVALLARI, Larisa H; JOHNSON, Julie A et al.Thrombosis and haemostasis. 2013, Vol 109, Num 6, pp 1045-1050, issn 0340-6245, 6 p.Article

Effect of the VKORC1 D36Y variant on warfarin dose requirement and pharmacogenetic dose predictionKURNIK, Daniel; QASIM, Husam; SOMINSKY, Sophie et al.Thrombosis and haemostasis. 2012, Vol 108, Num 4, pp 781-788, issn 0340-6245, 8 p.Article

Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapyHORNE, Benjamin D; LENZINI, Petra A; PENDLETON, Robert C et al.Thrombosis and haemostasis. 2012, Vol 107, Num 2, pp 232-240, issn 0340-6245, 9 p.Article

  • Page / 166